Epigenetic Reactivation of Estrogen receptor-α (ERα) by Genistein Enhances Hormonal Therapy Sensitivity in ERα-negative Breast Cancer

Mol Cancer. 2013 Feb 4;12:9. doi: 10.1186/1476-4598-12-9.

Abstract

Background: Estrogen receptor-α (ERα)-negative breast cancer is clinically aggressive and normally does not respond to conventional estrogen target-directed therapies. The soybean isoflavone, genistein (GE), has been shown to prevent and inhibit breast cancer and recent studies have suggested that GE can enhance the anticancer capacity of an estrogen antagonist, tamoxifen (TAM), especially in ERα-positive breast cancer cells. However, the role of GE in ERα-negative breast cancer remains unknown.

Methods: We have evaluated the in vitro and in vivo epigenetic effects of GE on ERα reactivation by using MTT assay, real-time reverse transcription-polymerase chain reaction (RT-PCR) assay, western-blot assay, immunoprecipitation (ChIP) assay, immunohistochemistry and epigenetic enzymatic activity analysis. Preclinical mouse models including xenograft and spontaneous breast cancer mouse models were used to test the efficacy of GE in vivo.

Results: We found that GE can reactivate ERα expression and this effect was synergistically enhanced when combined with a histone deacetylase (HDAC) inhibitor, trichostatin A (TSA), in ERα-negative MDA-MB-231 breast cancer cells. GE treatment also re-sensitized ERα-dependent cellular responses to activator 17β-estradiol (E2) and antagonist TAM. Further studies revealed that GE can lead to remodeling of the chromatin structure in the ERα promoter thereby contributing to ERα reactivation. Consistently, dietary GE significantly prevented cancer development and reduced the growth of ERα-negative mouse breast tumors. Dietary GE further enhanced TAM-induced anti-cancer efficacy due at least in part to epigenetic ERα reactivation.

Conclusions: Our studies suggest that soybean genistein can epigenetically restore ERα expression, which in turn increases TAM-dependent anti-estrogen therapeutic sensitivity in vitro and in vivo. The results from our studies reveal a novel therapeutic combination approach using bioactive soybean product and anti-hormone therapy in refractory ERα-negative breast cancer which will provide more effective options in breast cancer therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticarcinogenic Agents / administration & dosage
  • Anticarcinogenic Agents / pharmacology*
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / pharmacology*
  • Azacitidine / analogs & derivatives
  • Azacitidine / pharmacology
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / prevention & control
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNA (Cytosine-5-)-Methyltransferases / metabolism
  • Decitabine
  • Drug Resistance, Neoplasm / drug effects
  • Drug Synergism
  • Epigenesis, Genetic / drug effects*
  • Estradiol / pharmacology
  • Estrogen Receptor alpha / genetics*
  • Estrogen Receptor alpha / metabolism
  • Female
  • Gene Expression / drug effects
  • Genistein / administration & dosage
  • Genistein / pharmacology*
  • Histone Deacetylase 1 / metabolism
  • Histone Deacetylase Inhibitors / pharmacology
  • Histones / metabolism
  • Humans
  • Hydroxamic Acids / pharmacology
  • Mice
  • Mice, Nude
  • Mice, Transgenic
  • Proliferating Cell Nuclear Antigen / metabolism
  • Promoter Regions, Genetic
  • Tamoxifen / administration & dosage
  • Tamoxifen / pharmacology*
  • Tumor Burden / drug effects
  • Xenograft Model Antitumor Assays

Substances

  • Anticarcinogenic Agents
  • Antineoplastic Agents, Hormonal
  • Estrogen Receptor alpha
  • Histone Deacetylase Inhibitors
  • Histones
  • Hydroxamic Acids
  • Proliferating Cell Nuclear Antigen
  • estrogen receptor alpha, human
  • Tamoxifen
  • trichostatin A
  • Estradiol
  • Decitabine
  • Genistein
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNA (Cytosine-5-)-Methyltransferases
  • HDAC1 protein, human
  • Histone Deacetylase 1
  • Azacitidine